The Netherlandsdsm-firmenich.com
Owner Investor / Financier Operator Developer Technology licensor
dsm-firmenich is a global Swiss–Dutch specialty chemicals and ingredients company formed in 2023 from the combination of DSM and Firmenich. The company develops and produces flavors, fragrances, taste solutions, nutrition and health ingredients, enzymes, vitamins, and aroma molecules for customers in food and beverage, perfumery, home and personal care, dietary supplements, pharmaceuticals, and animal nutrition.
With R&D and manufacturing operations worldwide, dsm-firmenich integrates biotechnology, fermentation, and advanced formulation to deliver functional ingredients and sensorial solutions. The company emphasizes responsible sourcing and energy use across its supply chain and operates with dual headquarters in Switzerland and the Netherlands.
Also known as DSM - Firmenich AG.
chemXplore tracks 18 projects involving dsm-firmenich, of which 2 are active.
Besides these 2, the record holds 16 completed projects.
Closest to start-up first.
The 16 that are completed, on hold or cancelled are in the record. See all 18 in chemXplore
New automated unit makes highly hydrogenated pine‑based rosin resins for adhesives, coatings and chewing gum; targets Europe, North America and Asia while valorizing >90% of co‑products.
The feed additive reduces enteric methane emissions by around 30% on average, with results varying by diet, dose and feeding conditions.
Creative hub houses nine fine‑fragrance perfumers, about 100 staff, a next‑gen lab with Cerberus compounding robot (456 raw materials) and the OPEN AIR cultural programme.
Exclusive global distribution of GMP‑grade biopharma vitamins for cell culture media; eight B‑vitamin products, multi‑pack sizes and CPHI Milano debut.
New Jakarta Creative Center consolidates labs and co-creation spaces; Karawang expansion adds drying and blending capabilities and reduces CO₂ via electrification and heat recovery.
Boltz foundation models will be applied to ingredient discovery to predict and design scent and flavor molecules using dsm-firmenich’s receptor data, with platform access and embedded researchers.
Patent suit in China alleges unauthorized biotech production of sclareol, seeks injunction and damages; defendants include a sclareol producer and a research institute.
Board chair Thomas Leysen will retire; shareholders will vote on Richard Ridinger at an Extraordinary General Meeting on 19 Oct 2026.
active all projects
What each is building and closing, and the pipelines and grids between them, on one map.